Stock BIOBLAST PHARMA LTD
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Bioblast Pharma Ltd Nasdaq

Equities

IL0011319527

Biotechnology & Medical Research

Business Summary

Enlivex Therapeutics Ltd is an Israel-based clinical stage macrophage reprogramming immunotherapy company developing Allocetra, off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. AllocetraTM is a therapy designed to reprogram macrophages into their homeostatic state. Diseases such as solid cancers, sepsis, COVID-19 and many others reprogram macrophages out of their homeostatic state. These non-homeostatic macrophages contribute significantly to the severity of the respective diseases. By restoring macrophage homeostasis, AllocetraTM has the potential to provide immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents.

Managers

Managers TitleAgeSince
Oren Hershkovitz CEO
 Chief Executive Officer 47 19-11-15
Dror Mevorach FOU
 Founder 68 08-12-31
Shachar Shlosberger DFI
 Director of Finance/CFO 47 15-12-31
Veronique Amor-Baroukh COO
 Chief Operating Officer - -
Sigal Arad HRO
 Human Resources Officer - -
Iris Tavor LAW
 General Counsel - -
Einat Galamidi PRN
 Corporate Officer/Principal - 22-02-21
Oren Elmaliah AUD
 Comptroller/Controller/Auditor 40 17-01-31

Members of the board

Members of the board TitleAgeSince
Shai Novik CHM
 Chairman 58 13-12-31
Avri Havron BRD
 Director/Board Member 76 13-12-31
Brian Schwartz BRD
 Director/Board Member 52 20-11-30
Roger Pomerantz BRD
 Director/Board Member 67 22-05-22
Gili Hart BRD
 Director/Board Member 49 13-12-31
Andrew Singer BRD
 Director/Board Member 53 23-04-16

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 18,811,781 15,198,104 ( 80.79 %) 0 80.79 %

Shareholders

NameEquities%Valuation
Kip Global Pharma Ecosystem Private Equity Fund
7.628 %
1,417,950 7.628 % 2 M $
Hadasit Bio-Holdings Ltd. /Private Equity/
5.412 %
1,006,007 5.412 % 1 M $
Shai Novik
4.055 %
753,764 4.055 % 1 M $
Dror Mevorach
1.262 %
234,657 1.262 % 340 253 $
Avri Havron
0.9568 %
177,852 0.9568 % 257 885 $
Morgan Stanley Capital Services LLC
0.3880 %
72,120 0.3880 % 104 574 $
Renaissance Technologies LLC
0.3760 %
69,889 0.3760 % 101 339 $
Susquehanna Securities LLC
0.3655 %
67,943 0.3655 % 98 517 $
Citadel Securities GP LLC
0.2987 %
55,525 0.2987 % 80 511 $
KSM Mutual Funds Ltd.
0.2516 %
46,766 0.2516 % 67 811 $

Company contact information

Enlivex Therapeutics Ltd.

14 Einstein Street

7403618, Ness Ziona

+

http://www.enlivex.com
address Bioblast Pharma Ltd

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+9.42% 114B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+11.84% 104B
BIONTECH SE Stock BioNTech SE
-14.15% 22.41B
ARGENX SE Stock argenx SE
-1.05% 22.28B
GENMAB A/S Stock Genmab A/S
-5.29% 19.07B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-38.29% 18B
BEIGENE, LTD. Stock BeiGene, Ltd.
-4.16% 17.89B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+7.99% 14.28B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+36.24% 12.55B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. ENLV Stock
  4. Stock
  5. Company Bioblast Pharma Ltd
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW